Nouveau Life Pharmaceuticals, Inc. and Puration, Inc. announced that Brian Shibley, the current CEO PURA has been appointed as the interim CEO of NOUV. On October 4, 2018, PURA sold its cannabis cultivation business to NOUV in exchange for a $1.2 million convertible note with a commitment that the note would promptly be converted into shares of NOUV and that those converted shares would be distributed in a stock dividend to the shareholders of PURA. Brian Shibley's appointment as CEO is anticipated to reaccelerate the update of NOUV public filings and in so doing, speed up the anticipated dividend of NOUV shares to PURA shareholders.